SENATE COMMITTEE ON HUMAN SERVICES

 

 

March 10, 2005                                                                                                       Hearing Room D

3:00 P.M.                                                                                                                     Tapes  32 - 34

 

MEMBERS PRESENT:         Sen. Bill Morrisette, Chair

Sen. Jeff Kruse, Vice-Chair

Sen. Laurie Monnes Anderson

Sen. Charles Starr

 

MEMBER EXCUSED:          Sen. Rick Metsger

 

STAFF PRESENT:                 Rick Berkobien, Committee Administrator

Brittany Kenison, Committee Assistant

 

MEASURES/ISSUES HEARD:

SB 772 – Public Hearing

 

These minutes are in compliance with Senate and House Rules.  Only text enclosed in quotation marks reports a speaker’s exact words.  For complete contents, please refer to the tapes.

 

TAPE/#

Speaker

Comments

TAPE 32, A

003

Chair Morrisette

Calls the meeting to order at 3:03 p.m.  Opens a public hearing on SB 772.

SB 772 – PUBLIC HEARING

010

Rick Berkobien

Committee Administrator.  Explains the bill.

016

Rep. Steve March

House District 46.  Testifies in support of SB 772.

048

Grant Higginson

MD, MPH, State Public Health Officer, Health Services, Oregon Department of Human Services.  Submits and presents written testimony on the background of SB 772 (EXHIBIT A).

100

Higginson

Continues reviewing written testimony describing SB 772.

148

Sen. Kruse

Asks if the bill is under the Health Insurance Portability and Accountability Act (HIPAA).

151

Higginson

Responds that it is outside of HIPAA.  Elaborates.

157

Chair Morrisette

Asks to explain HIPAA.

162

Sen. Kruse

Explains HIPAA.  Asks if the federal level has concerns with the bill.

173

Higginson

Answers question.

182

Sen. Kruse

States possible concerns.

183

Higginson

Notes that there is no fiscal impact.  Summarizes and concludes.

215

Brian Michaels

Attorney, Eugene, Oregon.  Testifies in support of SB 772.

265

Michaels

Explains changes needed to the bill.

315

Michaels

Continues discussing changes needed to the bill.

325

Sen. Kruse

Comments that the drug schedule is federal.  Asks how the state of Oregon complies with federal law since Marijuana is classified as Schedule I.

330

Michaels

Explains that Oregon has its own drug scheduling.  Elaborates.

345

Sen. Kruse

Provides another example where Oregon is out of compliance with the federal schedule.

350

Michaels

Explains that Sen. Kruse’s comment is incorrect and explains.

354

Sen. Kruse

Asks if other states with a medical marijuana law have changed their state scheduling of Marijuana.

360

Michaels

Answers question.

362

Richard Bayer

MD, Fellow of the American College Physicians (FACP). Filing Chief Petitioner.  Co-author, OMMA.  Submits and presents written testimony providing background on SB 772 and changes needed (EXHIBIT B).

410

Bayer

Continues discussing changes needed for SB 772.

465

Craig Durbin

Lieutenant, Commander Oregon State Drug Enforcement Section.  Submits and presents written testimony in opposition to SB 772 (EXHIBIT C).

TAPE 33, A

040

Chair Morrisette

Asks Durbin to explain Affirmative Defense.

043

Durbin

Explains.

050

Chair Morrisette

Asks how patients prove that they need more than the legal amount of plants.

058

Durbin

Answers inquiry.

060

Chair Morrisette

Clarifies that he wanted Affirmative Defense explained for the record.

063

Durbin

Continues discussing opposition to the bill.

110

Durbin

Summarizes and concludes.

120

Dewey Patten

Lieutenant, Jackson County Narcotic Enforcement Team (JACNET).  Testifies in opposition to SB 772.

155

Chair Morrisette

Asks Durbin and Patten to provide recommendations for the bill.

160

Durbin

Provides recommendations.

183

Patten

Also provides recommendations.

190

Chair Morrisette

States that he would like to have witnesses submit written testimony of recommendations in a public work session.

230

Stormy Ray

Chief Petitioner, OMMA.  Testifies in support of SB 772 and submits information from previous legislation (EXHIBIT D) and a summary of changes of the 2005 Legislative Session to the Medical Marijuana Act (EXHIBIT E).  States that the medical Marijuana program needs education and has lack of information.

280

Ray

Continues to testify in support of SB 772.

330

Ray

Summarizes and concludes.

360

Chair Morrisette

Asks if Marijuana plants can be grown year round in a greenhouse.

363

Ray

Answers, yes.  Elaborates.

366

Jerry Wade

Citizen, Oregon.  Testifies in support of SB 772.  Discusses experience as a disabled Veteran.

370

James Babcock

Citizen, Dundee, Oregon.  Submits and presents written testimony in support of SB 772 (EXHIBIT F).

420

Babcock

Continues discussing SB 772.

TAPE 32, B

015

Chair Morrisette

Comments on commercialized business that could grow plants in compliance with Oregon laws.

020

Babcock

Comments on the Chair’s proposed idea.

023

Chair Morrisette

Comments on a business to supply plants and asks why it has not been done yet.

028

Babcock

Speculates.

032

Chair Morrisette

Discusses study that shows the medical benefits of Marijuana.  Discusses how to get away from loop holes in the law.  Discusses the need to take away temptation from producing Marijuana illegally.

048

Sen. C Starr

Asks to clarify that the drug level can vary per plant.

050

Babcock

Affirms.  Discusses federal hearing for medical Marijuana. 

080

Sen. Starr

Comments that the quantity needs to be addressed.

083

Babcock

Responds.  Also states concern that it is not clear in law who owns the plant.

108

Chair Morrisette

Asks what the cost of the medical Marijuana card was originally.

110

Babcock

Answers question.

112

Chair Morrisette

Asks if it is against federal law to receive Marijuana from the cost of the card.

115

Babcock

Responds.

120

Chair Monnes Anderson

Re-clarifies question.

122

Babcock

Answers re-clarification.

125

Chair Morrisette

Discusses need to address law enforcements issues.

145

Sen. Kruse

Comments on doing experiments, but cannot because of restrictive laws.

160

Al Hayward

Former investigative reporter.  Testifies in support of SB 772.

220

John Sajo

Former Director, Voter Power.  Former Chief Petitioner, Measure 33.  Submits and presents written testimony in support of SB 772 with proposed changes (EXHIBIT G).

270

Sajo

Continues to review proposed changes of SB 772.

300

Chair Morrisette

Requests specific changes from the public.

305

Linda Taylor

Citizen, Oregon.  Testifies in support of SB 772.

365

Laird Funk

Former advocate that began the medical Marijuana law.  Testifies in support of SB 772.

390

Lindsey Bradshaw

Citizen, Williams, Oregon.  Testifies in support of SB 772.

440

Bradshaw

Continues to testify in support of SB 772.

460

Tim Mullins

Citizen, Sumpter, Oregon.  Testifies in support of SB 772.

TAPE 33, B

010

Mullins

Continues to testify in support of SB 772.

020

Bradshaw

Adds comments about the procurement of the medicine as a group project.

035

Angelique Yeakle

Citizen, Oregon.  Testifies in support of SB 772.

065

Teresa Sheffer

Citizen, Oregon.  Testifies in support of SB 772.

090

Jennifer Abboud

Citizen, Oregon.  Submits and presents written testimony in support of SB 772 (EXHIBIT H).

165

Muriel Hockett

Citizen, Salem, Oregon.  Submits and presents written testimony in support of SB 772 (EXHIBIT I).

185

Greg Byers

Citizen, Salem, Oregon.  Submits and presents written testimony in support of SB 772 (EXHIBIT J).

235

Ron Ayers

Citizen, Oregon.  Testifies in support of SB 772.

265

Hal Ballard

Citizen, Oregon.  Testifies in support of SB 772 but addresses concerns of the bill.

315

Ballard

Continues to address concerns of the bill.

345

Christopher Rich

Oregon Medical Marijuana Act (OMMA) Caregiver.  Submits and presents written testimony in opposition to SB 772 (EXHIBIT K).

395

Chris Iverson

Director, Voter Power.  Submits and presents written testimony in support of SB 772. (EXHIBIT L).

TAPE 34, A

015

Sen. Kruse

Comments on the number of Oregonians who voted for Measure 33 (2004).

020

Dr. Phillip Leveque

Forensic Toxicologist, Osteopathic Physician, Molalla, Oregon.  Submits and presents written testimony in support of SB 772 (EXHIBIT M).

070

Erin Hilderbrandt

Citizen, Lafayette, Oregon.  Submits and presents written testimony in support of SB 772 (EXHIBIT N).

087

Chair Morrisette

Notes that he needs to leave and Sen. Kruse will chair the remainder of the hearing.

090

Clifford Spencer

Citizen, Oregon.  Submits and presents written testimony in support of SB 772 (EXHIBIT O).

140

Spencer

Continues to testify in support of SB 772.

190

Kristi Carrick

Citizen, Oregon.  Testifies in support of SB 772.

210

Casey Ferguson

Citizen, Eugene, Oregon.  Testifies in support of SB 772.

245

Leland Berger

Attorney, Portland, Oregon.  Submits and presents written testimony in support of SB 772 (EXHIBIT P).

285

Vice-Chair Kruse

Asks Berger to submit proposed amendments to the committee administrator.

288

Berger

Notes that he attached it to the written testimony.  States appreciation of the bill.

300

Walter Haggan

Citizen, Oregon.  Testifies in support of SB 772.

335

Steve Dingle

Marion County Deputy District Attorney, on behalf of the Oregon District Attorney’s Association.  Submits and presents written testimony in opposition to SB 772 (EXHIBIT Q).

The following material is submitted for the record without public testimony:

 

John English

Citizen, Oregon.  Submits an informational packet in support of SB 772 (EXHIBIT R).

 

Rachel Rose

Patient, Medical Marijuana program.  Citizen, Portland, Oregon.  Submits written testimony in support of SB 772 (EXHIBIT S).

 

Sandee Burbank

Director, Mothers Against Misuse and Abuse (MAMA). Submits written testimony without a stated position to SB 772 (EXHIBIT T).

380

Vice-Chair Kruse

Closes public hearing on SB 772 and adjourns meeting at 5:30 p.m.

EXHIBIT SUMMARY

 

A.     SB 772, written testimony, Grant Higginson, 3 pp

B.     SB 772, written testimony, Richard Byer, 2 pp

C.     SB 772, written testimony, Craig Durbin, 3 pp

D.    SB 772, informational packet, Stormy Ray, 12 pp

E.     SB 772, summary of changes, Stormy Ray, 2 pp

F.      SB 772, written testimony, James Babcock, 2 pp

G.    SB 772, written testimony, John Sajo, 3 pp

H.    SB 772, written testimony, Jennifer Abboud, 2pp

I.       SB 772, written testimony, Muriel Hockett, 2 pp

J.      SB 772, written testimony, Kenneth Byers, 3 pp

K.    SB 772, written testimony, Christopher Rich, 3 pp

L.     SB 772, written testimony, Chris Iverson, 1 p

M.  SB 772, written testimony, Phillip Leveque, 1 p

N.    SB 772, written testimony, Erin Hildebrandt, 2pp

O.    SB 772, written testimony, Clifford Spencer, 2 pp

P.      SB 772, written testimony, Leland Berger, 5 pp

Q.    SB 772, written testimony, Steve Dingle, 6 pp

R.    SB 722, written testimony, John English, 16 pp

S.      SB 772, written testimony, Rachel Rose, 2 pp

T.     SB 772, written testimony, Sandee Burbank, 13 pp